The Claim

Nausea is a common adverse effect of exenatide treatment in obese, nondiabetic women, with 56% of users experiencing it; however, the severity of nausea diminishes over time and is not correlated with the degree of weight loss achieved during treatment.

Source: Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
56score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

Lots of obese women who aren't diabetic feel nauseous when they start taking a drug called exenatide for weight loss — about 56 out of every 100. But the queasiness usually gets better over time, and how much weight they lose doesn’t seem to depend on how bad the nausea is.

See the scientific wording

Nausea is a common adverse effect of exenatide treatment in obese, nondiabetic women, affecting 56% of users, but its severity decreases over time and it does not correlate with degree of weight loss.

What the research says

1 study

  1. Study: Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes

    The study looked at the same medicine and people described in the claim, and found that nausea was common, got better over time, and didn’t affect how much weight people lost.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.